EVOX 10-K & 10-Q changes, risk factors and insider trading
Evolution Global Acquisition Corp (also EVOXU, EVOXW) · Nasdaq · Blank Checks · CIK 2077954 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
Factors that could cause our actual results to differ materially from those in this Quarterly Report include the risk factors described in our Annual Report on Form 10-K filed with the SEC on March 3, 2026. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 3, 2026.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“For the period from June 26, 2025 (inception) through June 30, 2025, cash used in operating activities was $0. Net loss of $20,818 was affected by payment of operating expenses through promissory note – related party of $12,430 and payment of operating expenses by Sponsor in exchange for issuance of Class B ordinary shares of $8,388.”see in full comparison
“For the six months ended June 30, 2026, we had net income of $3,887,040, which consisted of interest earned on investments held in Trust Account of $4,274,712, partially offset by operating costs of $387,672.”see in full comparison
For thesee in full comparisonthreesix months endedMarch31,June 30, 2026, cash used in operating activities was$109,835.$254,705. Net income of$1,951,845$3,887,040 was affected by interest earned on investments held in the Trust Account of$2,120,916.$4,274,712. Changes in operating assets and liabilitiesusedprovided$59,236$132,967 of cash for operating activities.
“For the period from June 26, 2025 (inception) through June 30, 2025, we had net loss of $20,818 which consisted of formation and operational costs.”see in full comparison
For the three months endedsee in full comparisonMarchJune31,30, 2026, we had net income of$1,951,845,$1,935,195, which consisted of interest earned on investments held in Trust Account of$ 2,120,916,$2,153,796, partially offset by operating costs of$169,071.$218,601.
As ofsee in full comparisonMarchJune31,30, 2026, we had investments held in the Trust Account of$243,327,660$245,481,456 (including$3,327,660$5,481,456 of interest income) consisting of U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
Full comparison: every changed paragraph (16)
We are a blank check company incorporated in the Cayman Islands on
June 26, 2025, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization
or other similar business combination with one or more businesses. We intend to effectuate our business combination using cash derived
from the proceeds of the Initial Public Offering and the sale of the privatePrivate placementPlacement units,Warrants, our shares, debt or a combination of cash,
shares and debt.
We have neither engaged
in any operations nor generated any revenues to date. Our only activities from June 26, 2025 (inception) through MarchJune 31,30, 2026 were
organizational activities and those necessary to prepare for the Initial Public Offering, described below, and, after our Initial Public
Offering, identifying a potential target company for a business combination. We do not expect to generate any operating revenues until
after the completion of our business combination. Subsequent to the Initial Public Offering, we generate non-operating income in the
form of interest income on investments held in the trust account. We incur expenses as a result of being a public company (for legal,
financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months
ended MarchJune 31,30, 2026, we had net income of $1,951,845,$1,935,195, which consisted of interest earned on investments held in Trust Account of $
2,120,916,$2,153,796, partially offset by operating costs of $169,071.$218,601.
For the six months ended June 30, 2026, we had net income of $3,887,040, which consisted of interest earned on investments held in Trust Account of $4,274,712, partially offset by operating costs of $387,672.
For the period from June 26, 2025 (inception) through June 30, 2025, we had net loss of $20,818 which consisted of formation and operational costs.
Following the Initial Public
Offering, the full exercise of the over-allotment option, and the sale of the Private Units,Placement Warrants, a total of $240,000,000 was placed in the
Trust Account. We incurred transaction costs of $15,036,813, consisting of $4,320,000 of cash underwriting fee (net of $480,000 underwriters’
reimbursement), $9,600,000 of deferred underwriting fee, and $1,116,813 of other offering costs.
For the threesix months ended
March 31,June 30, 2026, cash used in operating activities was $109,835.$254,705. Net income of $1,951,845$3,887,040 was affected by interest earned on investments
held in the Trust Account of $2,120,916.$4,274,712. Changes in operating assets and liabilities usedprovided $59,236$132,967 of cash for operating activities.
For the period from June 26, 2025 (inception) through June 30, 2025, cash used in operating activities was $0. Net loss of $20,818 was affected by payment of operating expenses through promissory note – related party of $12,430 and payment of operating expenses by Sponsor in exchange for issuance of Class B ordinary shares of $8,388.
As of MarchJune 31,30, 2026, we
had investments held in the Trust Account of $243,327,660$245,481,456 (including $3,327,660$5,481,456 of interest income) consisting of U.S. Treasury Bills
with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially
all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes
payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration
to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the
operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of MarchJune 31,30, 2026, we had
cash and cash equivalents of $1,010,726.$842,432. We intend to use the funds held outside the Trust Account primarily to identify and evaluate
target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar
locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective
target businesses, and structure, negotiate and complete a Business Combination.
We have no obligations,
assets or liabilities, which would be considered off-balance sheet arrangements as of MarchJune 31,30, 2026.
Critical Accounting PoliciesEstimates
We accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”, whereby under that provision, the warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, we evaluated and classified the warrant instruments under equity treatment at their assigned value. Such guidance provides that the warrants described above will not be precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity in accordance with ASC 480 and ASC 815.
We account for our ordinary
shares subject to possible conversionredemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic
480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability
instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights
that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary
shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future
events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of
the shareholders’ equity section of our condensed balance sheets.
Net Income (Loss) Per Ordinary Share
We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. We have two classes of shares, Class A Ordinary Shares and Class B Ordinary Shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per Ordinary Share is computed by dividing net income (loss) by the weighted average number of Ordinary Shares outstanding for the period. Accretion associated with the redeemable Ordinary Shares is excluded from income (loss) per Ordinary Share as the redemption value approximates fair value.
EVOX insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding EVOX (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 719,997 | $7.2M | 0.0% | No change |
| Two Sigma Investments | 2026-06-30 | 380,625 | $3.8M | 0.0% | No change |
| Millennium Management (Israel Englander) | 2026-06-30 | 336,000 | $3.4M | 0.0% | No change |